Your browser doesn't support javascript.
Bioactivity, bioavailability, and gut microbiota transformations of dietary phenolic compounds: implications for COVID-19.
Augusti, Paula R; Conterato, Greicy M M; Denardin, Cristiane C; Prazeres, Inês D; Serra, Ana Teresa; Bronze, Maria R; Emanuelli, Tatiana.
  • Augusti PR; Instituto de Ciência e Tecnologia de Alimentos, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil. Electronic address: paularaugusti@gmail.com.
  • Conterato GMM; Laboratório de Fisiologia da Reprodução Animal, Departamento de Agricultura, Biodiversidade e Floresta, Centro de Ciências Rurais, Universidade Federal de Santa Catarina, Campus de Curitibanos, Curitibanos, SC, Brazil.
  • Denardin CC; Universidade Federal Do Pampa, Campus Uruguaiana, Uruguaiana, RS, Brazil.
  • Prazeres ID; iBET, Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal; Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal.
  • Serra AT; iBET, Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal; Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal.
  • Bronze MR; iBET, Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal; Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal; iMED, Faculdade de Farmácia da Universidade de Lisboa, Lisboa, Portugal.
  • Emanuelli T; Núcleo Integrado de Desenvolvimento em Análises Laboratoriais (NIDAL), Departamento de Tecnologia e Ciência dos Alimentos, Universidade Federal de Santa Maria, Santa Maria, RS, Brazil.
J Nutr Biochem ; 97: 108787, 2021 11.
Article in English | MEDLINE | ID: covidwho-1253236
ABSTRACT
The outbreak of mysterious pneumonia at the end of 2019 is associated with widespread research interest worldwide. The coronavirus disease-19 (COVID-19) targets multiple organs through inflammatory, immune, and redox mechanisms, and no effective drug for its prophylaxis or treatment has been identified until now. The use of dietary bioactive compounds, such as phenolic compounds (PC), has emerged as a putative nutritional or therapeutic adjunct approach for COVID-19. In the present study, scientific data on the mechanisms underlying the bioactivity of PC and their usefulness in COVID-19 mitigation are reviewed. In addition, antioxidant, antiviral, anti-inflammatory, and immunomodulatory effects of dietary PC are studied. Moreover, the implications of digestion on the putative benefits of dietary PC against COVID-19 are presented by addressing the bioavailability and biotransformation of PC by the gut microbiota. Lastly, safety issues and possible drug interactions of PC and their implications in COVID-19 therapeutics are discussed.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Phenols / Anti-Inflammatory Agents, Non-Steroidal / Dietary Supplements / Gastrointestinal Microbiome / COVID-19 / Antioxidants Topics: Traditional medicine Limits: Animals / Humans Language: English Journal: J Nutr Biochem Journal subject: Biochemistry / Nutritional Sciences Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Phenols / Anti-Inflammatory Agents, Non-Steroidal / Dietary Supplements / Gastrointestinal Microbiome / COVID-19 / Antioxidants Topics: Traditional medicine Limits: Animals / Humans Language: English Journal: J Nutr Biochem Journal subject: Biochemistry / Nutritional Sciences Year: 2021 Document Type: Article